Alveo Technologies
Biotechnology ResearchCalifornia, United States51-200 Employees
Alveo Technologies is a mid-sized biotechnology company based in Alameda, California. It has developed a portable, multiplex-capable diagnostic platform that detects nucleic acid amplification directly, delivering rapid and affordable results at the point of need. The technology is designed to enable early pathogen detection across settings such as farms, clinics, and manufacturing facilities, supporting global health, food security, and supply-chain resilience. Its customer markets span agricultural operations, clinical environments, and industrial production contexts. In December 2025, Alveo announced a strategic partnership with Global Animal Health to deploy its poultry avian influenza test at scale in Egypt.